RK

Reena Kanwar

Active Director Director DIN 09707358
DIN 09707358 First appointment Aug 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value •••• Premium profile

About Reena Kanwar

Data last updated:

Reena Kanwar is a Director at Famynova Life Sciences Private Limited (since 2022). The company operates in Pharma. Famynova Life Sciences Private Limited reported revenue of ₹32 Lakh (FY 2024).

DIN 09707358
Primary Designation Director
Industry Pharma
First Appointment 18 Aug 2022
Oldest Company Age 4 yrs
Largest company Famynova Life Sciences Private Limited · ₹32 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Aug 20222022₹32 Lakh (FY 2024)Active

Board colleagues of Reena Kanwar

NameDINCompanyDesignation
Monika Patidar09707357Famynova Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Famynova Life Sciences Private Limited
Premium access

Shareholding and investment profile for Reena Kanwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Kanwar

Reena Kanwar currently holds 1 directorship: Famynova Life Sciences Private Limited (Director, since 18 Aug 2022, revenue ₹32 Lakh (FY 2024)).

Reena Kanwar was first appointed on 18 Aug 2022 as Director at Famynova Life Sciences Private Limited.

The current boards of Reena Kanwar's companies include Monika Patidar (Famynova Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available